Cargando…

USP14 Regulates DNA Damage Response and Is a Target for Radiosensitization in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents ~85% of the lung cancer cases. Despite recent advances in NSCLC treatment, the five-year survival rate is still around 23%. Radiotherapy is indicated in the treatment of both early and advanced stage NSCLC; however, treatment response in patients is hete...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Arishya, Almasan, Alexandru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503721/
https://www.ncbi.nlm.nih.gov/pubmed/32887472
http://dx.doi.org/10.3390/ijms21176383